Clinical Trials in Seattle

Showing 2801-2820 of 9,312 trials

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

NCT05039177

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies. * To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 administered in combination with other cancer therapies. * To evaluate the antitumor activity of ERAS-007 in combination with other cancer therapies. * To evaluate the PK profiles of ERAS-007 and other cancer therapies when administered in combination.

Metastatic Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma

Erasca, Inc.102 participantsStarted Sep 2021

Birmingham, Alabama, United States • Duarte, California, United States • Orange, California, United States +11 more locations

RECRUITINGNA< 1 mile

Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault

NCT06444295

The goal of this study is to find the most effective and efficient version of the THRIVE app. The THRIVE app is the first app-based preventative intervention that has been found to reduce alcohol misuse and posttraumatic stress in people who have recently experienced sexual assault. In this trial, participants are randomly assigned to receive different versions of the THRIVE app to compare their impact. The THRIVE app is currently only available to participants in this study.

Posttraumatic Stress SymptomAlcohol DrinkingAlcohol Problem

University of Washington464 participantsStarted Jul 2024

Seattle, Washington, United States

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault

Find Trials by Condition in Seattle

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

The Community Youth Development Study: A Test of Communities That Care

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Precision Nutrition Impact on Health-Related Behavior Change

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

Promoting Cognitive Health in Schizophrenia

Rapid Normalization of Vitamin D Deficiency in PICU

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

A Study of Imvotamab in Severe Systemic Lupus Erythematosus

Foot and Ankle Post-operative Oedema Management Using Geko™